Login

Mike Timoney, Chief Executive Officer for Smiles Inclusive (SIL) 00:00:00

Share On Facebook Share On Twitter

Mike Timoney, Chief Executive Officer for Smiles Inclusive (SIL)

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
David Cutler CEO, Centric Health Corporation
00:10:00
Mastering Fund Management: Key Concepts for FRM Candidates | Michael Reeves - Senior Analyst, AnalystPrep
00:10:00
Desert Lion Energy Showcases Prominent Lithium Project at One-to-One Conference
00:10:00
Navigating Early-Stage Innovation: Strategies from Genesis to Exit
00:10:00
Expanding access to investing insurance and retirement security|Robert M. Falzon,Vice Chair,Prudential Equity Investors
00:10:00
address large-scale problems in human and environmental health|Gareth Asten,Managing Partner,Acre Venture Partners
00:10:00
Positive Market Outlook: Key Sectors for Growth
00:10:00
NT's Defence Destination: Nicole Manison's ADM Congress Speech | Nicole Manison - Minister of Northern Territory
00:10:00
Mt Malcolm Mines’ Trevor Dixon Discusses Future Prospects for WA Gold Projects at RIU Sydney | Trevor Dixon, CEO , Mt Malcolm Mines.
00:10:00
Emphasizing the Vital Role of Collaborative Knowledge in Regional Development Amidst Unforeseen Challenges| Cristian Vergara Castillo, CEO, Essbio SA.
00:10:00
Mastering Emotional Investing: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants
00:10:00
FTE's two new projects |Michael P. Beys ,Interim Chief Executive Officer at FTE Networks Inc

© 2017 - Neuhu+